Numinus Wellness IncTSX:NUMIView on OTCQB
- LAST PRICE0.0300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0250/ 1,120
- Ask / Lots0.0300/ 545
- Open / Previous Close0.0300 / 0.0300
- Day Range
- 52 Week Range
- Volume36,215
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | NUMI |
|---|---|---|
| 09:32 ET | 22000 | 0.03 |
| 10:15 ET | 10000 | 0.03 |
| 10:42 ET | 3000 | 0.03 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Numinus Wellness Inc | 9.7M | -0.3x | --- |
Medicure Inc | 9.2M | -3.5x | --- |
Immunoprecise Antibodies Ltd | 14.6M | -0.7x | --- |
Avicanna Inc | 35.8M | -3.9x | --- |
Microbix Biosystems Inc | 44.8M | 9.2x | --- |
StageZero Life Sciences Ltd | 4.9M | 0.0x | --- |
Company Information
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.
Contact Information
- Headquarters
- 393 Laurier Ave WMONTREAL, QC, Canada H2V 2K3
- Phone
- 604-329-2079
- Fax
- 604-329-2079
Executives
- Chairman of the Board, Chief Executive Officer
- Payton Nyquvest
- President, Chief Operating Officer, Director
- Michael Tan
- Interim Chief Financial Officer
- Melony Valleau
- Senior Vice President - Clinic Operations
- Jason Lapensee
- Chief Scientific Officer, Chief Medical Officer
- Paul Thielking
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.7M |
|---|---|
Revenue (TTM) | $20.1M |
Shares Outstanding | 322.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.54 |
EPS | $-0.09 |
Book Value | $0.05 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -106.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
